During the past decade, York Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 22 clinical trials were completed, i.e. on average, 244.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 13 clinical trials were completed. i.e. 433.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "York Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 19 trials, followed by "SWOG Cancer Research Network" with 4 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Alliance for Clinical Trials in Oncology" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "York Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "North Central Cancer Treatment Group" with 3 trials as a collaborator and "SWOG Cancer Research Network" with 3 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "York Hospital" are "Recurrent Breast Carcinoma" (4 trials), "Breast Adenocarcinoma" (3 trials), "Breast Cancer" (3 trials), "Stage IIIB Breast Cancer AJCC v7" (3 trials) and "Stage IIIC Breast Cancer AJCC v7" (3 trials). Many other conditions were trialed in "York Hospital" in a lesser frequency.

Most popular intervention types in "York Hospital" are "Drug" (28 trials), "Other" (27 trials), "Biological" (11 trials), "Radiation" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (18 trials), "Quality-of-Life Assessment" (9 trials), "Bevacizumab" (5 trials), "placebo" (5 trials) and "Docetaxel" (4 trials). Other intervention names were less common.

The vast majority of trials in "York Hospital" are 28 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "York Hospital". undefined are not yet recruiting, 2 are recruiting, 19 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in York Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in York Hospital, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".

York Hospital has several departments that took part in Clinical trials: "York Hospital's Oncology Treatment Center" - 14 trials